Alza is also preparing to enter the sale of medicines

--

Alza has recently invested in the company Other Corp from Zdice in Central Bohemia, which operates a pharmacy, the CzechCrunch website reported with a link to entries in the public register.

The document is signed on behalf of Alza by attorney Pavel Steinwicht, who has represented the company for a long time and is even listed as an indirect beneficial owner in the register of beneficial owners. The largest domestic e-shop was founded by one of the richest Czechs, Aleš Zavoral.

Jan Sadílek, who previously worked at Alza for four years as a marketing director, apparently negotiated the transaction on behalf of Other Corp.

A solution to frequent outages? Even seniors want delivery of prescription drugs

Homemade

“In order to expand the product range, a part of the business plant was purchased. For a long time, we perceive the topic of health as an interesting business opportunity, which is why we have it on the website and in the Alza.cz application as one of the main categories,” said Alza’s press spokesperson Eliška Čeřovská.

At the moment, according to her, it is, for example, dietary supplements or sports nutrition. “To further expand the offer of contact lenses, dermocosmetics or over-the-counter drugs, we need a pharmacy license. We want to provide our customers with the entire range of products in the field of health,” added spokeswoman Alzy.

According to experts, the preparation and processing of all permits can take half a year or even a year.

In the area of ​​e-shops with medicines, the big pharmacy chains Dr. Max and Benu, who after the success of brick-and-mortar branches, quickly went into the online world as well. Both chains have their own e-shops, and they also cooperate with online supermarkets – Benu s Rohlík, Dr. Max with Basket.

Alza entered the fight for a customer against the Polish Allegro

Economy

The article is in Czech

Tags: Alza preparing enter sale medicines

-

PREV Diversification in times of concentrated stock markets – Goldman Sachs research – FAEI.cz
NEXT Goldman Sachs selected stocks in Europe with sustainable dividend incomes